John-Joseph Borg
Impact in
- Toxicology top 2%
- Pharmacovigilance and Adverse Drug Reactions
-
- Tryptophan and brain disorders
Papers in
-
- Pharmacovigilance and Adverse Drug Reactions 8
-
- Pharmaceutical studies and practices 6
- Co-authors
- Robert Nisticò (3 shared papers)Michał Pirożyński (3 shared papers)Anthony Serracino‐Inglott (17 shared papers)Daniela Melchiorri (2 shared papers)Sara Merlo (1 shared paper)František Dráfi (1 shared paper)Tomas Salmonson (3 shared papers)Patricia Vella Bonanno (2 shared papers)
- Journals
- Expert Opinion on Drug Safety (3 papers)Drug Safety (2 papers)Current Medical Research and Opinion (1 paper)Drug Metabolism and Personalized Therapy (1 paper)Frontiers in Pharmacology (1 paper)
- Partner nations
- MaltaItalyNetherlands
In The Last Decade
John-Joseph Borg
25 papers receiving 417 citations
Peers
Comparison fields: 5 of 85
- Toxicology 107
- Biological Psychiatry 24
- Geriatrics and Gerontology 11
- Physiology 78
- Neurology 24
Countries citing papers authored by John-Joseph Borg
This map shows the geographic impact of John-Joseph Borg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John-Joseph Borg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John-Joseph Borg more than expected).
Fields of papers citing papers by John-Joseph Borg
This network shows the impact of papers produced by John-Joseph Borg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John-Joseph Borg. The network helps show where John-Joseph Borg may publish in the future.
Co-authors
The 25 scholars most cited alongside John-Joseph Borg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 85 | |
| 2 | 2021 | 52 | |
| 3 | 2023 | 50 | |
| 4 | 2013 | 50 | |
| 5 | 2012 | 31 | |
| 6 | 2015 | 27 | |
| 7 | 2020 | 25 | |
| 8 | 2020 | 21 | |
| 9 | 2009 | 16 | |
| 10 | 2017 | 14 | |
| 11 | 2023 | 12 | |
| 12 | 2013 | 10 | |
| 13 | 2015 | 9 | |
| 14 | 2021 | 7 | |
| 15 | 2014 | 7 | |
| 16 | 2016 | 5 | |
| 17 | 2017 | 4 | |
| 18 | 2021 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2022 | 3 |
About John-Joseph Borg
John-Joseph Borg is a scholar working on Toxicology, Pediatrics, Perinatology and Child Health, Economics and Econometrics, Physiology and Pharmacology, having authored 28 papers that have together received 443 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (9 papers), Pharmacovigilance and Adverse Drug Reactions (8 papers), Pharmaceutical studies and practices (6 papers), Biosimilars and Bioanalytical Methods (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Biomedical Ethics and Regulation (2 papers), Pharmaceutical Quality and Counterfeiting (2 papers) and Alzheimer's disease research and treatments (2 papers). The work is most often cited by research in Toxicology (107 citations), Biological Psychiatry (24 citations), Geriatrics and Gerontology (11 citations), Physiology (78 citations) and Neurology (24 citations). John-Joseph Borg has collaborated with scholars based in Malta, Italy and Netherlands. Frequent co-authors include Robert Nisticò, Michał Pirożyński, Anthony Serracino‐Inglott, Daniela Melchiorri, Sara Merlo, František Dráfi, Tomas Salmonson, Patricia Vella Bonanno, Dimitrios Kouvelas and Christian K. Schneider. Their work appears in journals such as Expert Opinion on Drug Safety, Drug Safety, Current Medical Research and Opinion, Drug Metabolism and Personalized Therapy and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.